Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Secret Squirrels hit! -- Ignore unavailable to you. Want to Upgrade?

To: Trumptown who wrote (3691)	1/6/1999 12:51:00 PM
From: DR. MEADE	Respond to of 12872

Wednesday January 6, 10:00 am Eastern Time Company Press Release SOURCE: Advanced Plant Pharmaceuticals, Inc. Advanced Plant Pharmaceuticals, Inc. - APPI - Announces that They Have Appointed Barry Clare as New Chief Operating Officer for the Company NEW YORK, Jan. 6 /PRNewswire/ -- Advanced Plant Pharmaceuticals, Inc. (OTC Bulletin Board: APPI - news) announced today that they have appointed Barry Clare as new Chief Operating Officer for the Company. Advanced Plant Pharmaceuticals, Inc. is very pleased to announce that they have entered into an employment contract with Mr. Barry Clare. Mr. Clare brings to the Company many years of varied business experience. Mr. Clare was the Founder and President of American Breaktime Industries, Inc., an institutional in-plant feeding company with sales over $7,000,000 annually. Mr. Clare more recently was the Vice President and President of Intermediaries Inc., and Venture Capital Stage, Inc. respectively. Intermediaries and Venture Capital Stage specialized in raising seed capital for promising growth companies with patented or proprietary technologies, arranging for bridge funding prior to public offerings, reverse mergers, Regulation D 504 offerings and mergers and acquisitions. During the past year Mr. Clare has acted as consultant for APPI. Mr. Clare is very excited about being given the opportunity to take APPI to the next level of business. Mr. Clare believes in APPI's products and technologies and wants to begin generating revenues for the Company through the distribution of APPI's current product line. The hiring of Mr. Clare continues to show APPI's focus on top management and dedication towards bringing the Company from a Bio-medical company to an income generating company. The company expects to announce further agreements in the near future. APPI is a company that develops innovative plant formulations and technology for clinical application. APPI has met FDA nutritional specifications for the marketing of its Lo-Chol in the USA, and has received the first IND from the FDA for a whole plant pharmaceutical which has potential as an immunomodulater in the treatment of patients infected with HIV, the virus that causes AIDS. APPI's Whole Plant Pharmaceutical Grade Process is trade secret and patent pending. Utilization of the APPI process converts a whole plant into the best standardized pharmaceutical grade product. This press release contains forward-looking statements. Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements. SOURCE: Advanced Plant Pharmaceuticals, Inc. ------------------------------------------------------------------------ More Quotes and News:Advanced Plant Pharmaceuticals Inc (OTC BB:APPI - news)Related News Categories: chemicals, medical/pharmaceutical ------------------------------------------------------------------------ Help ------------------------------------------------------------------------ Copyright © 1999 PRNewswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. See our Important Disclaimers and Legal Information. Questions or Comments?